Clinical Trial Update: Neoadjuvant Itraconazole in Non-small Cell Lung Cancer [EARLY_Phase 1]

View source ↗

Summary

Early-phase neoadjuvant trial evaluating itraconazole in non-small cell lung cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Itraconazole (Itraconazole)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Non-small Cell Lung Cancer | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2021-05-03